Ticker Details
Amylyx Pharmaceuticals, Inc.
IPO Date:	January 7, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.04B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.57 | 3.89%
Avg Daily Range (30 D):	$0.48 | 3.14%
Avg Daily Range (90 D):	$0.50 | 3.25%

Institutional Daily Volume
Avg Daily Volume:	1.17M
Avg Daily Volume (30 D):	1.26M
Avg Daily Volume (90 D):	1.03M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	75
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	1,839
Avg Institutional Trade:	$1.87M
Avg Institutional Trade (30 D):	$2.49M
Avg Institutional Trade (90 D):	$2.05M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.37M
Avg Closing Trade (30 D):	$3.38M
Avg Closing Trade (90 D):	$2.56M
Avg Closing Volume:	159.92K

News

Feb 19, 2026 @ 8:30 AM Global Amyotrophic Lateral Sclerosis Therapeutics ... Source: Custom Market Insights

Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight

Jul 14, 2025 @ 10:26 PM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C.

Jul 8, 2025 @ 1:00 AM AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Inves... Source: Bragar Eagel & Squire, P.C.

Oct 18, 2024 @ 11:26 AM Why Amylyx Pharmaceuticals Stock Was So Healthy Th... Source: Eric Volkman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.48	$-.37	$-.28
Diluted EPS	$-1.48	$-.37	$-.28
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-150.11M	$-41.28M	$-33M
Operating Income / Loss	$-159.27M	$-43.78M	$-36.61M
Cost of Revenue			$M
Net Cash Flow	$168.91M	$2.49M	$1.48M
PE Ratio